Balduino Tschiedel
Research Subjects
Research Interests
Balduino Tschiedel has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Augusto Pimazoni-Netto
Diabetes, Education and Control Group, Kidney Hospital, Federal University of Sao Paulo, Sao Paulo, SP Brazil
1 shared publication - Hermelinda Cordeiro Pedrosa
Unidade de Endocrinologia, Hospital Regional de Taquaritinga, Brasília, DF, Brasil
1 shared publication - Kenneth W. Strauss
BD Diabetes Care, Erembodegem, Belgium
1 shared publication - Laura Cudizio
Faculdade de Ciências Médicas da Santa Casa de São Paulo, Departamento de Pediatria, Divisão de Endocrinologia Pediátrica, São Paulo, SP, Brazil
1 shared publication - Laurence Hirsch
VP Medical Affairs, BD Diabetes Care, Franklin Lakes, NJ USA
1 shared publication - Luis Eduardo Calliari
Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 27 November 2018
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 10 (1) , 1-7
Insulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data
In 2014–2015, the largest international survey of insulin injection technique in patients with diabetes taking insulin was conducted in 42 countries, totaling 13,289 participants. In Brazil, patients from five public health centers were included. This study aims to evaluate insulin injection technique in Brazilian patients and compare results with Latin America (LatAm) and World data. The insulin Injection Technique Questionnaire (ITQ) survey consisted of an initial patient section (questions applied by an experienced nurse), followed by observation of injection technique and examination of the injection sites by the health care professional. In Brazil, 255 patients were evaluated: 25% had type 1 diabetes mellitus (T1DM) and 75% had T2DM. In this study, 79% of patients injected less than 4 times a day, and 17.3% used insulin pens, compared to 28% in LatAm and 86% worldwide. Syringes were used by 78% of patients in Brazil, compared to 65% in LatAm and 10% globally. Differences in needle length were substantial—nearly 64% in Brazil inject with 8 mm length needle compared to 48% in LatAm and 27% worldwide. Additionally, 48% of patients in Brazil skip doses, 80% reuse pen needles and 57% reuse syringes with 27% having lipohypertrophy by exam. Brazilian patients use syringes more and pens less, inject with larger needles and have more lipohypertrophy when compared to Latin America and World data. Their re-use of needles and syringes is also high. This study showed that in Brazil, teaching of proper injection technique has to be more widespread, and more intensive during diabetes educational sessions, and the type of delivered supplies must be updated to smaller, shorter needles preferred by patients, in order to facilitate adherence to treatment. From the ITQ, we conclude that there are many aspects of insulin injection technique that may be improved in Brazil.
- 27 November 2018
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 10 (1) , 1-7
Open AccessInsulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data
In 2014–2015, the largest international survey of insulin injection technique in patients with diabetes taking insulin was conducted in 42 countries, totaling 13,289 participants. In Brazil, patients from five public health centers were included. This study aims to evaluate insulin injection technique in Brazilian patients and compare results with Latin America (LatAm) and World data. The insulin Injection Technique Questionnaire (ITQ) survey consisted of an initial patient section (questions applied by an experienced nurse), followed by observation of injection technique and examination of the injection sites by the health care professional. In Brazil, 255 patients were evaluated: 25% had type 1 diabetes mellitus (T1DM) and 75% had T2DM. In this study, 79% of patients injected less than 4 times a day, and 17.3% used insulin pens, compared to 28% in LatAm and 86% worldwide. Syringes were used by 78% of patients in Brazil, compared to 65% in LatAm and 10% globally. Differences in needle length were substantial—nearly 64% in Brazil inject with 8 mm length needle compared to 48% in LatAm and 27% worldwide. Additionally, 48% of patients in Brazil skip doses, 80% reuse pen needles and 57% reuse syringes with 27% having lipohypertrophy by exam. Brazilian patients use syringes more and pens less, inject with larger needles and have more lipohypertrophy when compared to Latin America and World data. Their re-use of needles and syringes is also high. This study showed that in Brazil, teaching of proper injection technique has to be more widespread, and more intensive during diabetes educational sessions, and the type of delivered supplies must be updated to smaller, shorter needles preferred by patients, in order to facilitate adherence to treatment. From the ITQ, we conclude that there are many aspects of insulin injection technique that may be improved in Brazil.